Submit your research
Start your submission and get more impact for your research by publishing with us.
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Journal notices
Advancing Excellence in Thoracic Oncology: Breakthroughs and Impactful Discoveries
Curated by Giuseppe Giaccone (Cornell) and Sharon Pine (Univ. of Colorado), this collection showcases key advances in thoracic oncology: cancer biology, diagnostics, treatments, biomarkers, translational insights, early detection, and clinical care.
Editor's Pick: Explainable, Federated AI for Brain Tumor MRI Classification
This study combines privacy-preserving federated learning with explainable AI (Grad-CAM, saliency maps) to classify brain tumors on MRI as glioma, meningioma, pituitary, or none, reaching 94% accuracy with transparent, clinician-ready predictions
ESMO Oncology Congress 2026 in Madrid
We will attend the ESMO Congress 2026 from 23 to 27 October in Madrid, Spain. Clinicians, researchers, and health leaders will share practical work to improve cancer diagnosis and care. We look forward to seeing you there.
Editor’s Pick: The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment
This review examines how dysregulated TGF-β/Smad signalling drives fibrosis via fibroblast activation, EMT, and ECM accumulation across the liver, kidney, lung, heart, and skin, and frames the pathway as a pivotal antifibrotic therapeutic target
Editor's Pick: Mechanisms and Technologies in Cancer Epigenetics
This review maps the epigenetic mechanisms driving cancer (DNA methylation, histone modifications, chromatin remodeling, ncRNAs) and technologies reshaping the field, from single-cell and spatial epigenomics to multi-omics and CRISPR epigenome editing
Editors
See allchristina m. annunziata
American Cancer Society
Atlanta, United States
Specialty Chief Editor
Cancer Molecular Targets and Therapeutics
massimo broggini
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Specialty Chief Editor
Cancer Molecular Targets and Therapeutics
brian d adams
Brain Institute of America
New Haven, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
vaishali aggarwal
Department of Immunology, School of Medicine, University of Pittsburgh
Pittsburgh, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
